{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T16:19:37Z","timestamp":1783009177794,"version":"3.54.5"},"reference-count":99,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.lfs.2026.124541","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:42:30Z","timestamp":1781624550000},"page":"124541","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Beyond lipid-lowering effects: Challenges and insights in fenofibrate repurposing for oncology"],"prefix":"10.1016","volume":"401","author":[{"given":"Liu","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan-Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Peng","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Ning","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Zhen","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2026.124541_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.lfs.2026.124541_bb0010","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201606","article-title":"Lipid metabolism and cancer","volume":"218","author":"Bian","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2026.124541_bb0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40880-018-0301-4","article-title":"Lipid metabolism reprogramming and its potential targets in cancer","volume":"38","author":"Cheng","year":"2018","journal-title":"Cancer Commun. (Lond.)"},{"key":"10.1016\/j.lfs.2026.124541_bb0020","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.cell.2024.02.040","article-title":"Challenges and opportunities in oncology drug development and clinical research in China","volume":"187","author":"Wang","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2026.124541_bb0025","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1158\/0008-5472.CAN-22-3042","article-title":"Metformin reprograms tryptophan metabolism to stimulate CD8+ T-cell function in colorectal cancer","volume":"83","author":"Huang","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2026.124541_bb0030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13046-018-0731-5","article-title":"Metformin induces autophagy and G0\/G1 phase cell cycle arrest in myeloma by targeting the AMPK\/mTORC1 and mTORC2 pathways","volume":"37","author":"Wang","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2026.124541_bb0035","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1186\/s12885-024-12555-5","article-title":"Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines","volume":"24","author":"De la Cruz-L\u00f3pez","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lfs.2026.124541_bb0040","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s12964-023-01359-y","article-title":"Simvastatin induces pyroptosis via ROS\/caspase-1\/GSDMD pathway in colon cancer","volume":"21","author":"Xie","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.lfs.2026.124541_bb0045","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4093\/dmj.2020.0001","article-title":"Fibrates revisited: potential role in cardiovascular risk reduction","volume":"44","author":"Kim","year":"2020","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.lfs.2026.124541_bb0050","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4093\/dmj.2023.0168","article-title":"Role of fenofibrate use in dyslipidemia and related comorbidities in the Asian population: a narrative review","volume":"48","author":"Deerochanawong","year":"2024","journal-title":"Diabetes Metab. J."},{"key":"10.1016\/j.lfs.2026.124541_bb0055","article-title":"Fenofibrate for diabetic retinopathy","volume":"6","author":"Kataoka S.","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.lfs.2026.124541_bb0060","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.cell.2023.03.003","article-title":"Metastasis","volume":"186","author":"Gerstberger","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2026.124541_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114616","article-title":"Potentials of peroxisome proliferator-activated receptor (PPAR) \u03b1, \u03b2\/\u03b4, and \u03b3: an in-depth and comprehensive review of their molecular mechanisms, cellular Signalling, immune responses and therapeutic implications in multiple diseases","volume":"155","author":"Singh","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2026.124541_bb0070","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1210\/er.2018-00064","article-title":"Molecular actions of PPAR\u03b1 in lipid metabolism and inflammation","volume":"39","author":"Bougarne","year":"2018","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.lfs.2026.124541_bb0075","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1172\/JCI27989","article-title":"Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis","volume":"116","author":"Lefebvre","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2026.124541_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106786","article-title":"Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD)","volume":"192","author":"Qiu","year":"2023","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.lfs.2026.124541_bb0085","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1042\/bj20031565","article-title":"Peroxisomal-proliferator-activated receptor alpha activates transcription of the rat hepatic malonyl-CoA decarboxylase gene: a key regulation of malonyl-CoA level","volume":"378","author":"Lee","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.lfs.2026.124541_bb0090","doi-asserted-by":"crossref","first-page":"16184","DOI":"10.1021\/acs.jafc.3c00712","article-title":"Enhancement of PPAR\u03b1-inhibited leucine metabolism-stimulated \u03b2-casein synthesis and fatty acid synthesis in primary bovine mammary epithelial cells","volume":"71","author":"Huang","year":"2023","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.lfs.2026.124541_bb0095","doi-asserted-by":"crossref","first-page":"754","DOI":"10.5551\/jat.28720","article-title":"Transcriptome analysis of K-877 (a novel selective PPAR\u03b1 modulator (SPPARM\u03b1))-regulated genes in primary human hepatocytes and the mouse liver","volume":"22","author":"Raza-Iqbal","year":"2015","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.lfs.2026.124541_bb0100","doi-asserted-by":"crossref","first-page":"5336","DOI":"10.1002\/j.1460-2075.1996.tb00918.x","article-title":"PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene","volume":"15","author":"Schoonjans","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.lfs.2026.124541_bb0105","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1172\/JCI88894","article-title":"Distinct but complementary contributions of PPAR isotypes to energy homeostasis","volume":"127","author":"Dubois","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2026.124541_bb0110","article-title":"Versatile functions of hepatic lipase in lipoprotein metabolism","author":"Dijk","year":"2025","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.lfs.2026.124541_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009802","article-title":"Endothelial lipase mediates efficient lipolysis of triglyceride-rich lipoproteins","volume":"17","author":"Khetarpal","year":"2021","journal-title":"PLoS Genet."},{"key":"10.1016\/j.lfs.2026.124541_bb0120","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41569-021-00569-6","article-title":"PPAR control of metabolism and cardiovascular functions","volume":"18","author":"Montaigne","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.lfs.2026.124541_bb0125","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.lfs.2026.124541_bb0130","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41597-023-02253-5","article-title":"Global trends and forecasts of breast cancer incidence and deaths","volume":"10","author":"Xu","year":"2023","journal-title":"Sci. Data"},{"key":"10.1016\/j.lfs.2026.124541_bb0135","article-title":"Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-\u03baB pathway","volume":"14","author":"Li","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lfs.2026.124541_bb0140","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1186\/s12967-025-06692-z","article-title":"Knocking down hypoxia-induced semaphorin 6B may attenuate the progression of cervical cancer through regulating macrophage M2 polarization","volume":"23","author":"Yi","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.lfs.2026.124541_bb0145","first-page":"977","article-title":"Effects of PPAR and RXR ligands in semaphorin 6B gene expression of human MCF-7 breast cancer cells","volume":"28","author":"Murad","year":"2006","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.lfs.2026.124541_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.116818","article-title":"Inhibition of tumor migration and invasion by fenofibrate via suppressing epithelial-mesenchymal transition in breast cancers","volume":"483","author":"Chen","year":"2024","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.lfs.2026.124541_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114673","article-title":"Potassium channels, tumorigenesis and targeted drugs","volume":"162","author":"Xia","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2026.124541_bb0160","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cytogfr.2021.11.002","article-title":"Pathophysiological role of growth differentiation factor 15 (GDF15) in obesity, cancer, and cachexia","volume":"64","author":"Siddiqui","year":"2022","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.lfs.2026.124541_bb0165","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ccell.2023.01.009","article-title":"Metabolic programming and immune suppression in the tumor microenvironment","volume":"41","author":"Arner","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lfs.2026.124541_bb0170","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.3892\/ijo.2017.3956","article-title":"Fenofibrate inhibits tumour intravasation by several independent mechanisms in a 3-dimensional co-culture model","volume":"50","author":"Nguyen","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.lfs.2026.124541_bb0175","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2026.124541_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217061","article-title":"Hepatocellular carcinoma and lipid metabolism: novel targets and therapeutic strategies","volume":"597","author":"Cao","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2026.124541_bb0185","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1038\/s41598-019-39778-y","article-title":"Fenofibrate induces human hepatoma Hep3B cells apoptosis and necroptosis through inhibition of thioesterase domain of fatty acid synthase","volume":"9","author":"You","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2026.124541_bb0190","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1006\/taap.2002.9538","article-title":"Cytotoxic effect of peroxisome proliferator fenofibrate on human HepG2 hepatoma cell line and relevant mechanisms","volume":"185","author":"Jiao","year":"2002","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.lfs.2026.124541_bb0195","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ejcb.2011.02.005","article-title":"Fenofibrate suppresses growth of the human hepatocellular carcinoma cell via PPAR\u03b1-independent mechanisms","volume":"90","author":"Yamasaki","year":"2011","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.lfs.2026.124541_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26125868","article-title":"Osteopontin: its properties, recent studies, and potential applications","volume":"26","author":"Karasalih","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2026.124541_bb0205","doi-asserted-by":"crossref","first-page":"9174","DOI":"10.1038\/s41467-024-53023-9","article-title":"Osteopontin is a therapeutic target that drives breast cancer recurrence","volume":"15","author":"Gu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2026.124541_bb0210","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41419-018-0391-6","article-title":"The role of osteopontin in the progression of solid organ tumour","volume":"9","author":"Zhao","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2026.124541_bb0215","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00432-024-05658-w","article-title":"Osteopontin promotes tumor growth and metastasis and GPX4-mediated anti-lipid peroxidation in triple-negative breast cancer by activating the PI3k\/Akt\/mTOR pathway","volume":"150","author":"Guo","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.lfs.2026.124541_bb0220","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00210-023-02604-4","article-title":"Fenofibrate suppresses the progression of hepatoma by downregulating osteopontin through inhibiting the PI3K\/AKT\/Twist pathway","volume":"397","author":"Chen","year":"2024","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.lfs.2026.124541_bb0225","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/mc.22029","article-title":"Differential effects on lung cancer cell proliferation by agonists of glucocorticoid and PPAR\u03b1 receptors","volume":"53","author":"Liang","year":"2014","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.lfs.2026.124541_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10100363","article-title":"Fenofibrate interferes with the diapedesis of lung adenocarcinoma cells through the interference with Cx43\/EGF-dependent intercellular signaling","volume":"10","author":"Piwowarczyk","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.lfs.2026.124541_bb0235","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1056\/NEJMoa2409515","article-title":"Ponsegromab for the treatment of cancer cachexia","volume":"391","author":"Groarke","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2026.124541_bb0240","doi-asserted-by":"crossref","first-page":"E743","DOI":"10.1073\/pnas.1714703115","article-title":"Fenofibrate prevents skeletal muscle loss in mice with lung cancer","volume":"115","author":"Goncalves M.","year":"2018","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.lfs.2026.124541_bb0245","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ymthe.2022.12.016","article-title":"Leukemia inhibitory factor, a double-edged sword with therapeutic implications in human diseases","volume":"31","author":"Wang","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.lfs.2026.124541_bb0250","article-title":"Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia in mice","volume":"15","author":"Yang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2026.124541_bb0255","article-title":"Kinsenoside suppresses DGAT1-mediated lipid droplet formation to trigger ferroptosis in triple-negative breast cancer","volume":"26","author":"Yang","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2026.124541_bb0260","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/s41423-024-01199-x","article-title":"Lipid droplet accumulation mediates macrophage survival and Treg recruitment via the CCL20\/CCR6 axis in human hepatocellular carcinoma","volume":"21","author":"Wang","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.lfs.2026.124541_bb0265","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202501046R","article-title":"DGAT1 inhibition enhances olaparib-induced lipotoxic apoptosis in metastatic castration-resistant prostate cancer","volume":"39","author":"Morshed M.","year":"2025","journal-title":"FASEB J."},{"key":"10.1016\/j.lfs.2026.124541_bb0270","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41388-023-02878-1","article-title":"Targeting DGAT1 inhibits prostate cancer cells growth by inducing autophagy flux blockage via oxidative stress","volume":"43","author":"Cui","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2026.124541_bb0275","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.bbrc.2013.01.105","article-title":"Fenofibrate down-regulates the expressions of androgen receptor (AR) and AR target genes and induces oxidative stress in the prostate cancer cell line LNCaP","volume":"432","author":"Zhao","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2026.124541_bb0280","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1016\/j.bbrc.2018.08.024","article-title":"Fenofibrate inhibits the growth of prostate cancer through regulating autophagy and endoplasmic reticulum stress","volume":"503","author":"Tao","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2026.124541_bb0285","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1158\/1535-7163.993.3.8","article-title":"Transcriptome analysis of endometrial cancer identifies peroxisome proliferator-activated receptors as potential therapeutic targets","volume":"3","author":"Holland C.","year":"2004","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.lfs.2026.124541_bb0290","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(18)32470-X","article-title":"Cervical cancer","volume":"393","author":"Cohen","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2026.124541_bb0295","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000518509","article-title":"Fenofibrate exerts anticancer effects on human cervical cancer HeLa cells via caspase-dependent apoptosis and cell cycle arrest","volume":"87","author":"Song","year":"2022","journal-title":"Gynecol. Obstet. Investig."},{"key":"10.1016\/j.lfs.2026.124541_bb0300","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2026.124541_bb0305","first-page":"428","article-title":"Fenofibrate-induced mitochondrial dysfunction and metabolic reprogramming reversal: the anti-tumor effects in gastric carcinoma cells mediated by the PPAR pathway","volume":"12","author":"Chen","year":"2020","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.lfs.2026.124541_bb0310","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1053\/j.gastro.2019.05.057","article-title":"Intestinal PPAR\u03b1 protects against colon carcinogenesis via regulation of methyltransferases DNMT1 and PRMT6","volume":"157","author":"Luo","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2026.124541_bb0315","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jdermsci.2021.11.007","article-title":"N(6)-methyladenosine-modified long non-coding RNA AGAP2-AS1 promotes psoriasis pathogenesis via miR-424-5p\/AKT3 axis","volume":"105","author":"Xian","year":"2022","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.lfs.2026.124541_bb0320","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.bbrc.2016.01.169","article-title":"Fenofibrate inhibited pancreatic cancer cells proliferation via activation of p53 mediated by upregulation of LncRNA MEG3","volume":"471","author":"Hu","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2026.124541_bb0325","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(23)00821-8","article-title":"Cutaneous melanoma","volume":"402","author":"Long","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2026.124541_bb0330","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cbi.2013.07.008","article-title":"Fenofibrate suppresses melanogenesis in B16-F10 melanoma cells via activation of the p38 mitogen-activated protein kinase pathway","volume":"205","author":"Huang","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.lfs.2026.124541_bb0335","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1158\/1078-0432.CCR-05-2556","article-title":"Peroxisome proliferator-activated receptor alpha activation decreases metastatic potential of melanoma cells in vitro via down-regulation of Akt","volume":"12","author":"Grabacka","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2026.124541_bb0340","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s12094-019-02150-7","article-title":"The effect of fenofibrate, a PPAR\u03b1 activator on toll-like receptor-4 signal transduction in melanoma both in vitro and in vivo","volume":"22","author":"Dana","year":"2020","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.lfs.2026.124541_bb0345","article-title":"Treatment with the PPAR\u03b1 agonist fenofibrate improves the efficacy of CD8(+) T cell therapy for melanoma","volume":"31","author":"Hasanpourghadi","year":"2023","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.lfs.2026.124541_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107922","article-title":"Fenofibrate-mediated inhibition of tumor proliferation and progression by modulating the PTPN14\/MARK3\/Hippo signaling axis","volume":"220","author":"Liu","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.lfs.2026.124541_bb0355","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12943-025-02267-0","article-title":"Glioblastoma multiforme: insights into pathogenesis, key signaling pathways, and therapeutic strategies","volume":"24","author":"Pouyan","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.lfs.2026.124541_bb0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103452","article-title":"Radiosensitizing capacity of fenofibrate in glioblastoma cells depends on lipid metabolism","volume":"79","author":"Alkotub","year":"2025","journal-title":"Redox Biol."},{"key":"10.1016\/j.lfs.2026.124541_bb0365","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/s13046-023-02927-3","article-title":"AMPK-HIF-1\u03b1 signaling enhances glucose-derived de novo serine biosynthesis to promote glioblastoma growth","volume":"42","author":"Yun","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2026.124541_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217116","article-title":"Natural products reverse cisplatin resistance in the hypoxic tumor microenvironment","volume":"598","author":"Yang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2026.124541_bb0375","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1002\/tox.23369","article-title":"Fenofibrate inhibits hypoxia-inducible factor-1 alpha and carbonic anhydrase expression through activation of AMP-activated protein kinase\/HO-1\/Sirt1 pathway in glioblastoma cells","volume":"36","author":"Lin","year":"2021","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.lfs.2026.124541_bb0380","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.tranon.2019.04.006","article-title":"Chemically modified variants of fenofibrate with antiglioblastoma potential","volume":"12","author":"Stalinska","year":"2019","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.lfs.2026.124541_bb0385","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-021-08417-z","article-title":"The lipid-lowering drug fenofibrate combined with si-HOTAIR can effectively inhibit the proliferation of gliomas","volume":"21","author":"Zhu","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.lfs.2026.124541_bb0390","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/leu.2010.117","article-title":"Fenofibrate induces effective apoptosis in mantle cell lymphoma by inhibiting the TNFalpha\/NF-kappaB signaling axis","volume":"24","author":"Zak","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.lfs.2026.124541_bb0395","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41419-025-07566-4","article-title":"Molecular mechanisms underlying TXNIP's anti-tumor role in breast cancer, including interaction with a novel, pro-tumor partner: CAST","volume":"16","author":"Singh","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2026.124541_bb0400","doi-asserted-by":"crossref","DOI":"10.1186\/s11658-024-00626-1","article-title":"PTBP1 knockdown impairs autophagy flux and inhibits gastric cancer progression through TXNIP-mediated oxidative stress","volume":"29","author":"Wang","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.lfs.2026.124541_bb0405","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.bbrc.2015.03.138","article-title":"Fenofibrate suppressed proliferation and migration of human neuroblastoma cells via oxidative stress dependent of TXNIP upregulation","volume":"460","author":"Su","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.lfs.2026.124541_bb0410","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1080\/0284186X.2021.1954241","article-title":"Neuro-immune interactions in paclitaxel-induced peripheral neuropathy","volume":"60","author":"Vermeer","year":"2021","journal-title":"Acta Oncol."},{"key":"10.1016\/j.lfs.2026.124541_bb0415","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bbi.2021.01.004","article-title":"Targeting peroxisome proliferator-activated receptor-\u03b1 (PPAR-\u03b1) to reduce paclitaxel-induced peripheral neuropathy","volume":"93","author":"Caillaud","year":"2021","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.lfs.2026.124541_bb0420","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2147\/OTT.S191239","article-title":"Fenofibrate potentiates chemosensitivity to human breast cancer cells by modulating apoptosis via AKT\/NF-\u03baB pathway","volume":"12","author":"Sun","year":"2019","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.lfs.2026.124541_bb0425","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2013.09.025","article-title":"PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells","volume":"155","author":"Israelsen","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2026.124541_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217493","article-title":"Dual targeting PPAR\u03b1 and NPC1L1 metabolic vulnerabilities blocks tumorigenesis","volume":"612","author":"You","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.lfs.2026.124541_bb0435","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nrg2556","article-title":"Non-genetic heterogeneity--a mutation-independent driving force for the somatic evolution of tumours","volume":"10","author":"Brock","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.lfs.2026.124541_bb0440","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1002\/stem.3281","article-title":"CD44(+) cells determine fenofibrate-induced microevolution of drug-resistance in prostate cancer cell populations","volume":"38","author":"Wr\u00f3bel","year":"2020","journal-title":"Stem Cells"},{"key":"10.1016\/j.lfs.2026.124541_bb0445","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11010077","article-title":"Fenofibrate augments the sensitivity of drug-resistant prostate cancer cells to docetaxel","volume":"11","author":"Luty","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.lfs.2026.124541_bb0450","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41401-021-00638-z","article-title":"PPAR\u03b1 agonist fenofibrate relieves acquired resistance to gefitinib in non-small cell lung cancer by promoting apoptosis via PPAR\u03b1\/AMPK\/AKT\/FoxO1 pathway","volume":"43","author":"Wang","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.lfs.2026.124541_bb0455","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.bbacli.2014.08.001","article-title":"ATM, ATR and DNA-PKcs expressions correlate to adverse clinical outcomes in epithelial ovarian cancers","volume":"2","author":"Abdel-Fatah T.","year":"2014","journal-title":"BBA Clin."},{"key":"10.1016\/j.lfs.2026.124541_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e05097","article-title":"ATM inhibition synergizes with fenofibrate in high grade serous ovarian cancer cells","volume":"6","author":"Chen","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.lfs.2026.124541_bb0465","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.1158\/0008-5472.CAN-21-0052","article-title":"PPAR\u03b1 agonist fenofibrate enhances cancer vaccine efficacy","volume":"81","author":"Chekaoui","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2026.124541_bb0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122104","article-title":"Regulating T-cell metabolic reprogramming and blocking PD-1 co-promote personalized postoperative autologous nanovaccines","volume":"297","author":"Chang","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.lfs.2026.124541_bb0475","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ccell.2017.08.004","article-title":"Enhancing CD8+ T cell fatty acid catabolism within a metabolically challenging tumor microenvironment increases the efficacy of melanoma immunotherapy","volume":"32","author":"Zhang","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lfs.2026.124541_bb0480","first-page":"31","article-title":"Nanoparticle-mediated lipid metabolic reprogramming of T cells in tumor microenvironments for immunometabolic therapy","volume":"13","author":"Kim","year":"2021","journal-title":"Nanomicro Lett."},{"key":"10.1016\/j.lfs.2026.124541_bb0485","article-title":"Beyond lipids: fenofibrate in diabetic retinopathy and nephropathy","author":"Liu","year":"2025","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.lfs.2026.124541_bb0490","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.2147\/DDDT.S405266","article-title":"Fenofibrate attenuates renal tubular cell apoptosis by up-regulating MCAD in diabetic kidney disease","volume":"17","author":"Tang","year":"2023","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.lfs.2026.124541_bb0495","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1517\/14728222.2014.981153","article-title":"Fenofibrate enhances barrier function of endothelial continuum within the metastatic niche of prostate cancer cells","volume":"19","author":"Piwowarczyk","year":"2015","journal-title":"Expert Opin. Ther. Targets"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526003504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320526003504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T15:19:44Z","timestamp":1783005584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320526003504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":99,"alternative-id":["S0024320526003504"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124541","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond lipid-lowering effects: Challenges and insights in fenofibrate repurposing for oncology","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124541","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124541"}}